-
Company Profile
PLx Pharma Inc – Company Profile
PLx Pharma Winddown Corp (PLx Pharma), formerly PLx Pharma Inc, is a pharmaceutical company. It develops patent-protected delivery systems. The company offers products such as PLxGuard delivery system, PLxGuard pipeline products, and PL1100 and PL1200 ibuprofen products. Its PLxGuard delivery system is used in the enhancement of efficacy of drugs, GI safety development, new or extended patent protection, and new drug application solutions. PLx Pharma’s lead product candidate includes Vazalore 325 mg, which is a novel formulation of aspirin that...
Add to Basket -
Product Insights
Net Present Value Model: Vazalore
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Vazalore Drug Details Aspirin (Vazalore) is...
-
Product Insights
Hypoparathyroidism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hypoparathyroidism is decreased function of the parathyroid glands with underproduction of parathyroid hormone. This leads to low levels of calcium in the blood, often causing cramping and twitching of muscles (involuntary muscle contraction), and several other symptoms. The condition can be inherited, but it is also encountered after thyroid or parathyroid gland surgery, and it can be caused by immune system-related damage as well as a number of rarer causes. The treatment includes artificial form of the hormone that can...
-
Product Insights
Intermittent Claudication Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Intermittent claudication is caused by narrowing or blockage in the main artery that takes blood to the leg. Symptoms include burning or tingling sensation, decreased or absent pulse in the lower limb, pale or bluish skin, poor hair growth on the legs, and sores or wounds on the lower limb that heal slowly, and poorly. Risk factors include smoking, high cholesterol, high blood pressure, obesity, diabetes, age, and family history. The intermittent claudication - drugs in development report provides an...